FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308189612> ?p ?o ?g. }

• W4308189612 endingPage "75" @default.
• W4308189612 startingPage "67" @default.
• W4308189612 abstract "Most tumour response scoring systems for resected pancreatic cancer after neoadjuvant therapy score tumour regression. However, whether treatment-induced changes, including tumour regression, can be identified reliably on haematoxylin and eosin-stained slides remains unclear. Moreover, no large study of the interobserver agreement of current tumour response scoring systems for pancreatic cancer exists. This study aimed to investigate whether gastrointestinal/pancreatic pathologists can reliably identify treatment effect on tumour by histology, and to determine the interobserver agreement for current tumour response scoring systems.Overall, 23 gastrointestinal/pancreatic pathologists reviewed digital haematoxylin and eosin-stained slides of pancreatic cancer or treated tumour bed. The accuracy in identifying the treatment effect was investigated in 60 patients (30 treatment-naive, 30 after neoadjuvant therapy (NAT)). The interobserver agreement for the College of American Pathologists (CAP) and MD Anderson Cancer Center (MDACC) tumour response scoring systems was assessed in 50 patients using intraclass correlation coefficients (ICCs). An ICC value below 0.50 indicated poor reliability, 0.50 or more and less than 0.75 indicated moderate reliability, 0.75 or more and below 0.90 indicated good reliability, and above 0.90 indicated excellent reliability.The sensitivity and specificity for identifying NAT effect were 76.2 and 49.0 per cent respectively. After NAT in 50 patients, ICC values for both tumour response scoring systems were moderate: 0.66 for CAP and 0.71 for MDACC.Identification of the effect of NAT in resected pancreatic cancer proved unreliable, and interobserver agreement for the current tumour response scoring systems was suboptimal. These findings support the recently published International Study Group of Pancreatic Pathologists recommendations to score residual tumour burden rather than tumour regression after NAT." @default.
• W4308189612 created "2022-11-09" @default.
• W4308189612 creator A5001682484 @default.
• W4308189612 creator A5002090404 @default.
• W4308189612 creator A5005202372 @default.
• W4308189612 creator A5013277239 @default.
• W4308189612 creator A5015416945 @default.
• W4308189612 creator A5021270199 @default.
• W4308189612 creator A5023598971 @default.
• W4308189612 creator A5026697149 @default.
• W4308189612 creator A5026813010 @default.
• W4308189612 creator A5027694554 @default.
• W4308189612 creator A5030962207 @default.
• W4308189612 creator A5033772545 @default.
• W4308189612 creator A5037416658 @default.
• W4308189612 creator A5040284861 @default.
• W4308189612 creator A5040697057 @default.
• W4308189612 creator A5047380313 @default.
• W4308189612 creator A5048076417 @default.
• W4308189612 creator A5052650376 @default.
• W4308189612 creator A5057229016 @default.
• W4308189612 creator A5059525044 @default.
• W4308189612 creator A5062083052 @default.
• W4308189612 creator A5062118679 @default.
• W4308189612 creator A5063785731 @default.
• W4308189612 creator A5064975394 @default.
• W4308189612 creator A5072825310 @default.
• W4308189612 creator A5076811435 @default.
• W4308189612 creator A5079776850 @default.
• W4308189612 creator A5083013593 @default.
• W4308189612 creator A5089675343 @default.
• W4308189612 creator A5090080796 @default.
• W4308189612 date "2022-11-04" @default.
• W4308189612 modified "2023-10-18" @default.
• W4308189612 title "Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1)" @default.
• W4308189612 cites W1966976587 @default.
• W4308189612 cites W1998805086 @default.
• W4308189612 cites W2155243985 @default.
• W4308189612 cites W2345822778 @default.
• W4308189612 cites W2527179630 @default.
• W4308189612 cites W2799575632 @default.
• W4308189612 cites W2893052923 @default.
• W4308189612 cites W2912196744 @default.
• W4308189612 cites W2989935659 @default.
• W4308189612 cites W3004999728 @default.
• W4308189612 cites W3032616940 @default.
• W4308189612 cites W3092103339 @default.
• W4308189612 cites W3093245982 @default.
• W4308189612 cites W3094306249 @default.
• W4308189612 cites W3128594599 @default.
• W4308189612 cites W3201322194 @default.
• W4308189612 cites W3206910916 @default.
• W4308189612 cites W4226269919 @default.
• W4308189612 cites W4255898812 @default.
• W4308189612 cites W4285504239 @default.
• W4308189612 cites W4293773079 @default.
• W4308189612 doi "https://doi.org/10.1093/bjs/znac350" @default.
• W4308189612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36331867" @default.
• W4308189612 hasPublicationYear "2022" @default.
• W4308189612 type Work @default.
• W4308189612 citedByCount "4" @default.
• W4308189612 countsByYear W43081896122023 @default.
• W4308189612 crossrefType "journal-article" @default.
• W4308189612 hasAuthorship W4308189612A5001682484 @default.
• W4308189612 hasAuthorship W4308189612A5002090404 @default.
• W4308189612 hasAuthorship W4308189612A5005202372 @default.
• W4308189612 hasAuthorship W4308189612A5013277239 @default.
• W4308189612 hasAuthorship W4308189612A5015416945 @default.
• W4308189612 hasAuthorship W4308189612A5021270199 @default.
• W4308189612 hasAuthorship W4308189612A5023598971 @default.
• W4308189612 hasAuthorship W4308189612A5026697149 @default.
• W4308189612 hasAuthorship W4308189612A5026813010 @default.
• W4308189612 hasAuthorship W4308189612A5027694554 @default.
• W4308189612 hasAuthorship W4308189612A5030962207 @default.
• W4308189612 hasAuthorship W4308189612A5033772545 @default.
• W4308189612 hasAuthorship W4308189612A5037416658 @default.
• W4308189612 hasAuthorship W4308189612A5040284861 @default.
• W4308189612 hasAuthorship W4308189612A5040697057 @default.
• W4308189612 hasAuthorship W4308189612A5047380313 @default.
• W4308189612 hasAuthorship W4308189612A5048076417 @default.
• W4308189612 hasAuthorship W4308189612A5052650376 @default.
• W4308189612 hasAuthorship W4308189612A5057229016 @default.
• W4308189612 hasAuthorship W4308189612A5059525044 @default.
• W4308189612 hasAuthorship W4308189612A5062083052 @default.
• W4308189612 hasAuthorship W4308189612A5062118679 @default.
• W4308189612 hasAuthorship W4308189612A5063785731 @default.
• W4308189612 hasAuthorship W4308189612A5064975394 @default.
• W4308189612 hasAuthorship W4308189612A5072825310 @default.
• W4308189612 hasAuthorship W4308189612A5076811435 @default.
• W4308189612 hasAuthorship W4308189612A5079776850 @default.
• W4308189612 hasAuthorship W4308189612A5083013593 @default.
• W4308189612 hasAuthorship W4308189612A5089675343 @default.
• W4308189612 hasAuthorship W4308189612A5090080796 @default.
• W4308189612 hasBestOaLocation W43081896121 @default.
• W4308189612 hasConcept C104709138 @default.
• W4308189612 hasConcept C121608353 @default.
• W4308189612 hasConcept C126322002 @default.
• W4308189612 hasConcept C126838900 @default.

• next